It seems that coadministration of Alb-IFNβ and E7 peptide does not induce any noticeable toxic side effects and was able to suppress tumor growth and prolong survival rates of tumor-beating mice better than tumor bearing mice treated with IFNβ and E7 peptide. This evidence concerns the gene IFNB1 and neoplasm.